Your browser doesn't support javascript.
loading
A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.
Davis, Elizabeth J; Griffith, Kent A; Kim, Edward J; Ruch, Joshua M; McDonnell, Kevin J; Zalupski, Mark M.
Afiliación
  • Davis EJ; Department of Internal Medicine, Division of Hematology-Oncology.
  • Griffith KA; Department of Biostatistics, University of Michigan, Ann Arbor, MI.
  • Kim EJ; Department of Internal Medicine, Division of Hematology-Oncology.
  • Ruch JM; Department of Internal Medicine, Division of Hematology-Oncology.
  • McDonnell KJ; Department of Internal Medicine, Division of Hematology-Oncology.
  • Zalupski MM; Department of Internal Medicine, Division of Hematology-Oncology.
Am J Clin Oncol ; 41(2): 128-132, 2018 02.
Article en En | MEDLINE | ID: mdl-26535993

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Clin Oncol Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Clin Oncol Año: 2018 Tipo del documento: Article